Get the Stockscreener App
41.38
1.17%
0.48
Pre-market:
40.60
-0.78
-1.88%
Tectonic Therapeutic Inc stock is traded at $41.38, with a volume of 98,689.
It is up +1.17% in the last 24 hours and down -12.77% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
See More
Previous Close:
$40.90
Open:
$41.07
24h Volume:
98,689
Relative Volume:
0.88
Market Cap:
$610.47M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.89%
1M Performance:
-12.77%
6M Performance:
+150.79%
1Y Performance:
+0.00%
1-Day Range:
$39.55
$42.20
1-Week Range:
$38.14
$44.00
52-Week Range:
$15.00
$53.41
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
41.38 | 610.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Clarius Group LLC Invests $468,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic Highlights Pipeline and Financial Strength - TipRanks
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 8.8%Should You Sell? - MarketBeat
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Simply Wall St
AVROBIO, Inc. Announces Acceptance of Investigational New Drug Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis - Marketscreener.com
Tectonic Therapeutic (NASDAQ:TECX) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Sionna Therapeutics Appoints Dr. Marcella Kuhlman Ruddy and Dr. Jo Viney to its Board of Directors - citybiz
FMR LLC's Strategic Acquisition of Tectonic Therapeutic Inc Shar - GuruFocus.com
Geode Capital Management LLC Boosts Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Shares Acquired by Geode Capital Management LLC - MarketBeat
Tectonic Therapeutic: Protein Engineering Platform For GPCRs (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap UpTime to Buy? - MarketBeat
Tectonic Therapeutic: Waiting For A Pullback (NASDAQ:TECX) - Seeking Alpha
Relay Therapeutics (NASDAQ:RLAY) & Tectonic Therapeutic (NASDAQ:TECX) Critical Contrast - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighHere's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7.1%Should You Sell? - MarketBeat
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 5.5%Time to Buy? - MarketBeat
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $72.25 - MarketBeat
Fmr LLC Grows Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Fmr LLC Has $36.97 Million Holdings in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Verition Fund Management LLC Sells 25,902 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Walleye Capital LLC Raises Stock Holdings in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic to Host KOL Event on the Unmet Need in - GlobeNewswire
Acuta Capital Partners LLC Invests $415,000 in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Wells Fargo Initiates Coverage of Tectonic Therapeutic (TECX) with Overweight Recommendation - MSN
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewswire
Tectonic started at outperform by Raymond James, TX45 cited - MSN
Comparing Cellectis (NASDAQ:CLLS) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic started at outperform by Raymond James, TX45 cited (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Raymond James - MarketBeat
Tectonic Therapeutic initiated with an Outperform at Raymond James - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):